Ghent (Belgium), 2 September 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) and bonyf R&D team are excited to introduce a scientifically advanced formulation designed to provide rapid relief from the discomfort associated with heel and finger cracks.
Author: bonyf
Post
NitrAdine® Dental Effervescent Tabs: Revolutionizing dental hygiene with unrivalled disinfecting power
Ghent (Belgium), 9 August 2024, 6:00 p.m.; bonyf NV (Ticker: MLBON) is proud to highlight the exceptional efficacy of NitrAdine®, a leading product in the field of dental hygiene. Classified as a Class IIb medical device, NitrAdine® complies with the rigorous European Standards ensuring the highest level of safety and efficacy.
Post
Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives
Ghent (Belgium), 18 July 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is excited to highlight the exceptional capabilities of our Research and Development (R&D) team, whose innovative work has brought Olivafix® Gold to the forefront of denture adhesive technology.
Post
bonyf NV: bonyf’s 2023 financial statements made available
Knokke (Belgium), 28 June 2024, 6:00 p.m; bonyf NV (Ticker: MLBON) presents its 2023 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.
Post
Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream
Ghent (Belgium), 7 June 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is proud to reaffirm our commitment to R&D, as well as to highlight the proven effectiveness of our unique fast pain-relief mouth ulcer cream AphtoFix®.
Post
2024 Sales Forecast: Unprecedented Growth on the Horizon
Ghent (Belgium), 10 May 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is poised for exponential growth in 2024.
Post
bonyf exhibits at PLMA Amsterdam on 28-29 May 2024
Ghent (Belgium), 16 April 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is thrilled to announce that our company is expanding its clientele in 2024, largely attributed to our successful participation in last year's PLMA exhibition in Amsterdam.
Post
bonyf Advances to Phase 2 in Development of Alginate-Organic Denture Fixative Cream
Ghent (Belgium), 2 April 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is thrilled to announce the progression to Phase 2 in the development of its revolutionary Alginate-Organic Denture Fixative Cream.
Post
bonyf R&D creates major breakthrough with 100% natural-origin ingredients new denture fixative cream
Ghent (Belgium), 13 February 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) welcomes you to invest in its shares.
Post
New Key Partnerships
Ghent (Belgium), 11 January 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) has secured key partnerships with an Austria-German multinational and a leading pharma company in Ukraine.